I’m Thankful for the Bright Spots in This Market

Folks, I’m sure you’re tired of hearing this by now…

But the reality is that most investors have endured a miserable year in the markets.

The broad market S&P 500 Index is still down roughly 20% in 2022. And the tech-heavy Nasdaq Composite Index remains down about 30% over the same span.

That’s a historically bad year. But importantly… not everyone is suffering that much.

For example, subscribers to my Power Gauge Investor newsletter are likely thriving…

We’ve now closed four positions in the “Industry Monitor” portion of our model portfolio this year. The average return on these positions was around 8%.

And the nine open positions in this portfolio are outperforming the broad market as well. They’re currently up an average of about 1.4%.

Now, that doesn’t mean it’s time for me to take a victory lap. Most investors would prefer much better returns, of course.

But compared with just sitting in an index fund… we’ve weathered the storm well so far.

Put simply, even a handful of winning trades can offset an otherwise terrible year. And by continuing to focus on the “best of the best of the best” opportunities in Power Gauge Investor, we’ll keep offsetting the broad market pains that most investors have faced.

Now, what does all that have to do with Chaikin PowerFeed readers like you?

Well, it’s time for an early Thanksgiving treat…

You see, Power Gauge Investor subscribers receive access to the Power Gauge system. In it, they can access nearly every tool I’ve developed at Chaikin Analytics.

One of my favorite tools is the Chaikin Ideas panel…

In short, the Chaikin Ideas panel allows subscribers to quickly access the top 10 rated stocks in the listed categories. So with just a few clicks of the mouse, these folks can find many “bullish” opportunities that are bucking the terrible trend in the broad market.

And today, I’d like to share a few of those opportunities with you.

First, I’ll cover the Best of the Large Caps section of the Chaikin Ideas panel. More specifically, I’d like to call your attention to health insurer Cigna (CI). Take a look…

As you can see, Cigna earns a “very bullish” overall rating from the Power Gauge. In fact, this company has maintained a “bullish” or better rating for most of the year.

Not surprisingly, Cigna’s stock is soaring. It’s up roughly 50% since early February.

Be careful with this one, though. It just experienced a huge run higher. And I wouldn’t be surprised to see traders take profits in the coming days.

With that said, the Power Gauge sees further opportunity here. So you’ll want to keep a close eye on this stock.

Next, let’s turn our attention to the Best of the Nasdaq category. In this case, it makes the most sense to share a telling tidbit rather than focus on an individual stock…

Five of the 10 stocks in the Best of the Nasdaq category are biotechnology companies. Even better, they’re not flash-in-the-pan stocks. Most investors would recognize all five of them.

Put simply, we’ve spotted a trend. And using a tool that the highest-level Chaikin Analytics subscribers can access, I’ve confirmed that the biotech subsector is “bullish” right now.

I hope the takeaway is clear…

Most investors have endured an awful year in the markets. But that doesn’t mean you can’t find any opportunities…

When the S&P 500 is down roughly 20% like it is this year, just preserving capital can be a strategic win. And the Power Gauge is helping us find opportunities for that.

Even better, it can identify opportunities in outperforming stocks. That’s happening with Cigna this year.

And finally, it can help us spot burgeoning trends. That’s the case with biotech today.

So thank you for joining me on this journey. It’s a privilege to be able to share my research with you. And we’ll continue using the Power Gauge as a guiding light in this market storm.

Good investing,

Marc Chaikin

Scroll to Top